GeneID	MetaboliteID	CandidateAnnotation	SupportingSNPRecords	MinimumP	Scope	ThresholdP	Comparison	GenomeAnnotation
Glyma.16G165300	P01836	2-Hydroxynicotinic acid	2	4.20396870017452e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P19876	Catharine	2	7.25775291028841e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P34966	Cernuine	2	4.79024541716907e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P00272	Volkenin	1	4.72381275880588e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P00391	Diethylthiophosphoric acid	1	1.46702442725588e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P02094	7-Ethoxycoumarin	1	7.25201478333962e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P03530	Thiamin monophosphate	1	6.64711756868125e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P03774	Kikumycin B	1	5.86896783469282e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P03942	1-Phenyl-1-cyclohexene	1	4.15045039609691e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P04056		1	8.52587198914939e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P04092		1	7.83976811274706e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P04187	Dihydrolipoamide	1	7.76961813904488e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P04575	2R,9R-dihydroxy-3S,4S,7S,8S-diepoxy-5E,10-undecadien-1-ol	1	1.60312003567352e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P07144	Diguanosine diphosphate	1	7.14929553698795e-15	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P07381	Desmethyl Fluvoxamine	1	3.067226888712e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P09770	(E)-Methyl-4-hydroxycinnamate	1	4.01607017108411e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P11699	2-(2-Phenylethenylsulfonyl)ethenylbenzene	1	5.06102847871142e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P14158	Physalien	1	1.95531291686308e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P14345	Levetiracetam	1	5.74116590367632e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P15162		1	1.49216607364838e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P15957	Antibiotic BT 38	1	8.2415710428024e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P17500	Undec-4-enedioylcarnitine	1	4.3890907930476e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P20017		1	2.28947839933926e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P20304		1	7.08203846369283e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P21082	(2S)-2-Amino-4-sulfanylbutanal	1	6.98465234871505e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P21354	1alpha,5alpha-Epidithio-17a-oxa-D-homoandrostan-3,17-dione	1	2.13092532542793e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P21927	Peliglitazar	1	2.0377801098257e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P22413	(7E)-(3S, 6RS)-6,19-epidioxy-24,24-difluoro-9,10-seco-5(10),7-cholestadiene-3,25-diol	1	8.1975787925298e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P22654	Excavatolide D	1	9.78937534054194e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P22684	Anadur	1	4.66027907318765e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P23067	Juncenolide A	1	5.93792242840038e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P23879	Methyl taboganate	1	8.48274716570151e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P24774	Glutamine hydroxamate	1	8.24464185520271e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P25116	2,3,4,2',4',6'-Hexamethoxychalcone	1	1.06864234308449e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P25253	Lolitriol	1	1.48142185681447e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P25873	3-(2-Furanyl)-2-phenyl-2-propenal	1	5.16432956906301e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P26285		1	3.64624142561225e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P28012	Tubacetine	1	4.64033550948541e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P28613	Isorhamnetin 3-gentiotrioside-7-glucoside	1	2.6898334309418e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P29027	Bazzanin J	1	2.09280591949002e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P29753	Eremopetasitenin C2	1	8.80939608894424e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P30296		1	4.89709834663562e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P30769	Brivanib	1	8.99176213334211e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P32581	4-hydroxyoct-6-enoylglycine	1	9.67249929524153e-14	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P33390	Phenol, 2-(2H-benzotriazol-2-yl)-4,6-bis(1,1-dimethylpropyl)-	1	5.5813397267549e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P33463	1-Octen-3-ol	1	6.00778291833671e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P34419	1-(9Z-octadecenoyl)-2-(4,7-dioxo-5E-heptenoyl)-sn-glycero-3-phosphoserine	1	2.38957959890933e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P35219	Tetradenolide	1	7.73066609050527e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P37368		1	6.80257704938985e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P41820		1	9.01088864257534e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P41869	Scutebarbatine H	1	5.43306826774735e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P42118		1	3.09742204137918e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P42445	4-Amino-3-hydroxybutanoylcarnitine	1	5.8484101099973e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P42831	N-(33-(9Z,12Z-octadecadienoyloxy)-tritriacontanoyl)-heneicosasphinganine	1	2.72617803920879e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P43004		1	1.16994580662632e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P45177	Fargoside D	1	6.18395433488838e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P50455	Carrageenan, potassium salt of	1	8.58120169370563e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P51162	Cephalosporin P1	1	1.70436034794228e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.16G165300	P52095	Neoline	1	7.87668207328062e-11	overlap	1e-10	<	Wm82.a2.v1